Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic adenocarcinoma, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-09-17NCT07349537

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Revolution Medicines, Inc.18

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dana-Farber Cancer InstituteBostonUnited States626
Johns HopkinsBaltimoreUnited States7
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew YorkUnited States6
NEXTSan AntonioUnited States1
NEXT - DallasDallasUnited States1
NEXT - VirginiaFairfaxUnited States1
START - San AntonioSan AntonioUnited States7
START MidwestGrand RapidsUnited States79
Yale Cancer CenterNew HavenUnited States21